BFLY · Butterfly Network, Inc.
One customer — 10% of revenue (the three and six months ended June 30, 2026)
“For the three and six months ended June 30, 2026, one customer accounted for more than 10% of the Company’s total revenue.”
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
AI Brief
Q2 FY26 earnings call · Jul 30, 2026TL;DR. Butterfly Network reported record Q2 2026 revenue of $32.6M (up 39% YoY), record gross margin of 71%, and an adjusted EBITDA loss that improved 78% YoY, driven by Butterfly Embedded growth; the company is raising full-year 2026 revenue guidance to $119M-$123M and adjusted EBITDA loss guidance to $19M-$23M.
- + Q2 revenue rose 39% YoY to a record $32.6M, above guidance and consensus
- + Butterfly Embedded revenue surged 439% YoY to $10.8M, driven by the Midjourney partnership
- + Gross margin reached a record 71.4%, a 770 bps increase YoY
- + Adjusted EBITDA loss improved 78% YoY to $1.4M, beating guidance
- + Full-year 2026 revenue guidance raised to $119M-$123M (~22-26% growth) and adjusted EBITDA loss guided to $19M-$23M
- − Average selling price decreased 12% due to higher IQ Plus mix and VCOM deal pricing
- − Q2 cash usage of $13.3M increased versus $7.0M in the prior-year quarter
- − Operating expenses rose 19% YoY to $37.0M, including a step-up in other expenses to $3.6M from $2.0M
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BFLY
this stock
Butterfly Network, Inc.
|
$2.42B | +135.8% | +19.0% | — | 13.4% |
|
ABT
Abbott Laboratories
|
$174.90B | -21.1% | +5.7% | 28.1 | 1.1% |
|
MDT
Medtronic plc
|
$113.38B | -10.2% | +8.4% | 21.8 | 1.3% |
|
SYK
Stryker Corp
|
$104.47B | -21.6% | +11.2% | 28.2 | 2.0% |
|
BSX
Boston Scientific Corp
|
$63.59B | -54.2% | +12.5% | 17.8 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BFLY | -2.6% | +9.5% | +115.9% | +13.6% | +135.8% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | -1.9% | +9.4% | +103.7% | +14.1% | +124.0% |